External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma
NCT00271050
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma, B-Cell
Interventions
OTHER:
external beam radiotherapy plus 90-Y ibritumomab tiuxetan
Sponsor
The Cleveland Clinic